Emergent BioSolutions (EBS) Return on Capital Employed Growth (1y) (2012 - 2026)
Emergent BioSolutions (EBS) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,195.00 |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | 1,279.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,279.00 |
| Dec 31, 2025 | 1,651.00 |
| Sep 30, 2025 | 2,040.00 |
| Jun 30, 2025 | 5,151.00 |
| Mar 31, 2025 | 3,795.00 |
| Dec 31, 2024 | 5,164.00 |
| Sep 30, 2024 | 4,249.00 |
| Jun 30, 2024 | -1,436.00 |
| Mar 31, 2024 | -2,794.00 |
| Dec 31, 2023 | -5,076.00 |
| Sep 30, 2023 | -6,053.00 |
| Jun 30, 2023 | -3,588.00 |
| Mar 31, 2023 | -2,739.00 |
| Dec 31, 2022 | -2,288.00 |
| Sep 30, 2022 | -563.00 |
| Jun 30, 2022 | -959.00 |
| Mar 31, 2022 | -1,155.00 |
| Dec 31, 2021 | -489.00 |
| Sep 30, 2021 | 107.00 |
| Jun 30, 2021 | 390.00 |